Skip to main content
OpenTrials
Completed

NCT Number: NCT01619436

The Effect of Clonidine in Glycemia During Coronary Artery Bypass Graft With Cardiopulmonary By-pass

The purpose of this study is the randomized blind research of the assessment of the different levels of glycemia during Coronary Artery Bypass Graft (CABG) with cardiopulmonary by-pass (CPB) between clonidine and placebo. As clonidine decrease the inflammatory response during cardiac surgery, the investigators would like to know if the glycemia levels in clondine group will be lower than placebo group.

Completed

Looking for future studies?

Notify Me

Key information

Age range

45 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

National institut of Cardiology

Rio de Janeiro, 3600/100, Brazil

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • elective CABG EF > 40% Sinus ritmy

Exclusion criteria

  • precordialgia emergency surgery combinated surgery not agreement

Treatment and study plan

Clonidine

Drug

bolus, clonidine 2 mg/kg IV

Ringer lactato

Drug

1 ML ringer lactato IV, as placebo

Primary outcomes

  1. sedation

    Time frame: 2 years

    Clonidine 2 mg/kg IV. assessment sedation with Ransay scale

Secondary outcomes

  1. Glycemia

    Time frame: 2 years

    clonide 2 mg/kg. assessment the glycemia during CPB.

Sponsors and collaborators

Lead sponsor

Federal University of Juiz de Fora

Other

Registry information

Official study title

The Effect of Clonidine in Glycemia During Coronary Artery Bypass Graft With Cardiopulmonary By-pass.

Important dates

Study start
2011
Primary completion
2012
Study completion
2012
First posted
Jun 14, 2012
Registry last updated
Jun 14, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.